Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-26 @ 3:31 AM
Study NCT ID:
NCT01044420
Status:
UNKNOWN
Last Update Posted:
2010-01-07
First Post:
2010-01-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
mFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment of Paclitaxel/DDP : a Phase II Single Center Prospective Clinical Trial
Sponsor:
Peking University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-05
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2012-06
Completion Date Type:
ESTIMATED
First Submit Date:
2010-01-06
First Submit QC Date:
None
Study First Post Date:
2010-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-01-06
Last Update Post Date:
2010-01-07
Last Update Post Date Type:
ESTIMATED